Epilepsy Cured in Mice Using Brain Cells - Innovation Toronto
UC San Francisco Cell Therapy Raises Hope for Severe Human Forms
Stay updated with breaking news from Scottc Baraban. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
UC San Francisco Cell Therapy Raises Hope for Severe Human Forms
PARAMUS, N.J., Feb. 16, 2022 (GLOBE NEWSWIRE) -- Epygenix Therapeutics, Inc. ("Epygenix"), a clinical stage biopharmaceutical company focused on rare and...
/PRNewswire/ -- Epygenix Therapeutics, Inc. ("Epygenix"), a clinical stage biopharmaceutical company focused on rare and intractable genetic epilepsy,...
May 3, 2021 8:00am Emerging from stealth mode with a pipeline of FDA and EMA Orphan Drug Designation candidates, Epygenix Therapeutics Inc. is poised to become the first biopharmaceutical company to commercialize epilepsy drugs discovered in zebrafish. Epygenix Therapeutics’ six lead drug candidates were identified in a high-throughput phenotype-based drug screening system using a unique zebrafish model developed in the laboratory of Professor Scott C. Baraban, PhD at the University of California, San Francisco (UCSF). Founded in 2016, Epygenix Therapeutics has grown to become a clinical st...
Cronutt the sea lion's experimental brain surgery offers hope for dying sea mammals When Cronutt the sea lion wandered ashore in California three years ago, he was so disoriented and confused and that he tried to break into people's houses. Since then, his condition has only gotten worse. Social Sharing CBC Radio · Posted: Oct 12, 2020 4:54 PM ET | Last Updated: October 12, 2020 Cronutt the sea lion has undergone an experimental surgery to treat epilepsy caused by algae bloom toxins.(Dianne Cameron/University of California San Francisco)